Apalutamide will lower the level or influence of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medications that are CYP3A4 substrates may end up in reduced exposure to these medications. Usage of this site has long been denied https://gregorydugsf.pointblog.net/wymzya-fe-birth-control-options-72201097